AntiCancer, Inc. v. Fujifilm Medical Systems U.S.A., Inc.
3:09-cv-01311
Overview
Parties
Defendant
GE Healthcare Inc. Operating Company
Represented By
9 Attorneys ListedArnold & Porter Kaye Scholer, LLP
777 South Figueroa Street, 44th Floor
Arnold & Porter Kaye Scholer, LLP
601 Massachusetts Avenue, NW, Washington, DC 20001-3743
Orrick Herrington & Sutcliffe, LLP
1152 15th Street, NW, Washington, DC 20005
Arnold & Porter LLP
777 South Figueroa Street, 44th Floor
Arnold & Porter
Arnold & Porter, 777 South Figueroa Street
Orrick, Herrington & Sutcliffe LLP
777 South Figueroa Street, Suite 3200
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Orrick Herrington & Sutcliffe LLP
Izumi Garden Tower, 28F, 6-1 Roppongi 1-chome
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Fujifilm Corporation NPE (Individual / Inventor)
Represented By
5 Attorneys ListedOrrick Herrington & Sutcliffe, LLP
1152 15th Street, NW, Washington, DC 20005
Orrick, Herrington & Sutcliffe LLP
777 South Figueroa Street, Suite 3200
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Orrick Herrington & Sutcliffe LLP
Izumi Garden Tower, 28F, 6-1 Roppongi 1-chome
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Counter Claimant
Fujifilm Medical Systems U.S.A., Inc Operating Company
Represented By
5 Attorneys ListedOrrick Herrington & Sutcliffe, LLP
1152 15th Street, NW, Washington, DC 20005
Orrick, Herrington & Sutcliffe LLP
777 South Figueroa Street, Suite 3200
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Orrick Herrington & Sutcliffe LLP
Izumi Garden Tower, 28F, 6-1 Roppongi 1-chome
Orrick Herrington & Sutcliffe LLP
1152 15th Street, NW, Washington, DC 20005
Counter Defendant
Court & Judges
Court
District Court, S.D. California (casd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6251384
Metastasis models using green fluorescent protein (GFP) as a marker
|
Filed: 1999-01-07
Issued: 2001-06-26
|
Expired (Term Ended)
Expires: 2019-01-07
|
|
|
US6649159
Whole-body optical imaging of gene expression and uses thereof
|
Filed: 2001-03-19
Issued: 2003-11-18
|
Expired (Term Ended)
Expires: 2021-03-19
|
|
|
US6759038
Metastasis models using green fluorescent protein (GFP) as a marker
|
Filed: 2001-05-29
Issued: 2004-07-06
|
Expired (Term Ended)
Expires: 2021-05-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
2
Granted
1
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings